The RXKitted Blog
Operational insights for telehealth providers, compounding pharmacies, and anyone building in the peptide space.
The RFK Effect: What the 2026 Peptide Reclassification Means for Telehealth Providers
HHS Secretary Kennedy is moving 14 peptides back to Category 1 compounding eligibility. Here's what it means operationally and how to position your business.
Cold Chain Logistics for Peptide Shipping: The Ops Guide
Temperature requirements, packaging standards, ISTA 7E, failure points, and how to build a cold chain that holds up at scale.
The Complete Peptide Guide: What Each Compound Does and Its Compounding Status
BPC-157, CJC-1295, Ipamorelin, Thymosin Alpha-1, Semaglutide, Tirzepatide, and more — clinical use, mechanism, and current FDA category.
503A vs 503B Compounding: What Telehealth Operators Need to Know
A clear breakdown of the two compounding frameworks, which peptides each can compound, and the operational implications for your telehealth program.
Peptide API Sourcing: Why Pharmaceutical-Grade Matters
RUO vs pharmaceutical-grade, FDA-registered suppliers, Certificate of Analysis requirements, and red flags to watch for.
How to Launch a DTC Peptide Program: The Supply Ops Playbook
Step-by-step for telehealth companies launching peptide programs — from pharmacy partnership to kitting to patient doorstep.
Ready to build your kitting program?
Our materials have gone into over 2 million shipments from telehealth providers and compounding pharmacies. Let's talk about your program.